KemPharm, Inc. (KMPHD) News KMPHD Home News Ratings Charts KemPharm, Inc. (KMPHD): $8.25 1.06 (-11.39%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum NR Stability NR Sentiment Get Rating Quality NR Add KMPHD to Watchlist Sign Up Industry: Biotech Industry NR Ranked #NR of 481 in industry See All 'A' Rated Buy Stocks Filter KMPHD News Items All News Types Featured Stories AcquisitionAirlineAutomobilesBarron'sBiotechnologyBuffettBusiness/Consumer ServicesBuybackCommentaryCommoditiesConsumer GoodsCorp. NewsCramerDebt OfferingDefenseDividendDow Jones Industrial AverageDowngradeEarningsEconomic DataEnergyETFsFAANGFederal ReserveFinancialFood & BeverageGuidance DownGuidance UpHealthcareHedge FundHomebuildersInsider BuyingInsider SellingIPOsJob CutsLeisure/Arts/HospitalityM&AMarijuanaMediaMetals & MiningMgmt ChangeNew Coverage (Bearish)New Coverage (Bullish)New Coverage (Neutral)OptionsPE InvestmentProduct NewsPT LoweredPT RaisedPT Set (Bearish)PT Set (Bullish)PT Set (Neutral)Rating Reiterated (Bearish)Rating Reiterated (Bullish)Rating Reiterated (Neutral)Real EstateRestaurantsResumes Coverage (Bearish)Resumes Coverage (Bullish)Resumes Coverage (Neutral)RetailRumorSemiconductorSocial MediaSpin-offStock OfferingStock SplitTechnologyTelecomTransportation LogisticsTrumpUpgradeUtilities Search KMPHD News Results Date Symbol Company Title Start End Change POWR Rating Loading, please wait... Load More News Items Most Popular Stories View All • Updated 2024 Stock Market Outlook • Top 4 Tech Giants Poised for Explosive Growth • 3 Top Rated Software Stocks to Streamline Your Investments • Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)? • Investor Alert: “Buy the Rumor, Sell the News!” View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe